Sequenom Adopts Shareholder Rights Plan | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom today said that its board of directors has approved the adoption of a share purchase rights plan, under which shareholders of record at the close of business on March 20, will receive rights to purchase shares of a new series of preferred stock.

The plan is being put in place to "enable all stockholders of Sequenom to realize the full value of their investment and to provide for fair and equal treatment for all stockholders in the event that an unsolicited attempt is made to acquire Sequenom," the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.